Revvity (RVTY) Q3 revenue $729 million vs $712 million est.
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Revvity (NYSE: RVTY) reported third-quarter revenue of $729 million, topping the $712 million consensus estimate and rising from $699 million a year earlier. GAAP earnings per share from continuing operations came in at $0.56, up from $0.41 in the prior-year period, while GAAP operating income from continuing operations reached $95 million versus $82 million. The beat matters as a signal on demand trends across the company's life-sciences and diagnostics franchise amid a uneven tools market. Investors will watch for management's updated full-year outlook and any detail on order trends and margin trajectory on the accompanying call.
Muhabbit's AI wrote this summary in its own words from Business Wire's report. It can get details wrong, so check the source.
Named in this story
Revvity, Inc., Revvity (RVTY), NYSE: RVTY
A linked name opens that asset's sentiment page.